Symbol | Exchange | Currency |
---|
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Buy | Strong Buy | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
5.00 | 5.50 | 5.00 | -0.25 | -4.54% | 29.85M | London | |||
6,228.00 | 6,248.00 | 6,134.00 | +58.0 | +0.94% | 596.69K | London | |||
1.02 | 1.03 | 0.90 | 0.00 | 0.00% | 628.48K | Aquis Exchange | |||
92.12 | 92.50 | 86.66 | +1.74 | +1.93% | 1.35M | London | |||
127.36 | 127.76 | 126.32 | +0.70 | +0.55% | 76.46M | London | |||
4,834.50 | 4,937.50 | 4,765.00 | -82.0 | -1.67% | 2.62M | London | |||
3.90 | 3.90 | 3.90 | 0.00 | 0.00% | 0.00 | London | |||
2,509.00 | 2,521.00 | 2,445.00 | +31.0 | +1.25% | 493.39K | London | |||
788.40 | 790.80 | 788.00 | -0.60 | -0.08% | 2.50M | London | |||
1,910.00 | 1,930.00 | 1,892.00 | -32.0 | -1.65% | 31.43K | London | |||
365.10 | 371.50 | 360.20 | -1.60 | -0.44% | 2.00M | London | |||
0.69 | 0.69 | 0.69 | 0.00 | 0.00% | 0.00 | London | |||
3,165.00 | 3,165.00 | 3,105.00 | +30.0 | +0.96% | 157.59K | London | |||
256.60 | 260.20 | 248.80 | +2.40 | +0.94% | 785.16K | London | |||
187.50 | 189.10 | 181.10 | +3.30 | +1.79% | 395.35K | London |